Device / Technology News

RSS

Devax's AXXESS Biolimus A9 Eluting Coronary Bifurcation Stent System receives CE Mark approval

Devax, Inc. announced today the company received CE Mark for its AXXESS™ Biolimus A9® Eluting Coronary Bifurcation Stent System, allowing the company to initiate sales in the European Union and other countries that recognize the CE Mark.

29 Jul 2010

Online pharmacy services Pharmahelper.com, QC Supply, and Kerr Drug earn NABP e-Advertiser Approval

The National Association of Boards of Pharmacy® (NABP®) has named Pharmahelper.com, QC Supply, and Kerr Drug as the first online pharmacy services to be approved through the Association's new e-Advertiser Approval(CM) Program now required by Google, Microsoft, and Yahoo!. As such, these entities offer reliable and trustworthy resources for patients seeking to purchase medications safely online.

29 Jul 2010

NeoTract selects SYSPRO ERP

SYSPRO, the leading provider of visionary, pragmatic ERP software, today announced that NeoTract, Inc., a Medical Device start-up company headquartered in Pleasanton, Calif., has selected SYSPRO ERP (Enterprise Resource Planning) software to manage the company's financial, manufacturing and distribution operations.

29 Jul 2010

Ortho Kinematics: 23 patients enrolled in KineGraph VMA clinical study

Ortho Kinematics, a privately held spine diagnostics company focused on revolutionizing spine motion analysis, announced today that it has begun a multi-site clinical study of the KineGraph VMA™, and that the initial 23 patients have been enrolled. The study will help determine which types of patients are best evaluated with KineGraph VMA testing. The KineGraph VMA is designed to provide functional diagnostic information to spine surgeons to be used in conjunction with MRI and plain X-rays.

29 Jul 2010

Exact Sciences to demonstrate methylation specific technology at AACC annual meeting

Exact Sciences Corp. today announced that data being presented this afternoon at the annual meeting of the American Association of Clinical Chemistry demonstrates that its methylation specific technology, using a combination of DNA methylation markers, detected 100 percent of colorectal cancers and precancers at a specificity cutoff of 100 percent in a preliminary study with colorectal tissue.

29 Jul 2010

Rotigotine provides clinically relevant improvements in RLS symptoms: Study

UCB today announced the results of a 6-month, randomized, double-blind, placebo-controlled clinical study, published in the journal Movement Disorders, showing that Neupro® (rotigotine transdermal system, 2 and 3 mg/24 hours) provided sustained, clinically relevant improvements in symptoms of Restless Legs Syndrome (RLS). The study also showed high rates of complete remission seen with rotigotine 2 mg or 3 mg/24 hours.

29 Jul 2010

Positive results from phase I clinical trial of MultiStem in patients with AMI announced

Angiotech Pharmaceuticals, Inc. and partner Athersys, Inc. announced positive results from its phase I clinical trial of MultiStem, its allogeneic cell therapy product, administered to individuals following acute myocardial infarction, more commonly referred to as a heart attack.

29 Jul 2010

Reliance on assistive devices can affect everyday life in multiple ways: Study

Obese older adults are more likely to use walkers, canes and other mobility devices at a younger age, and may run the risk of using them incorrectly, according to new research from Purdue University.

29 Jul 2010

Noveko RD2 antimicrobial respirators obtain FFP2 classification

Noveko International Inc. is pleased to announce that its subsidiary Noveko Inc. has obtained FFP2 classification for its new model of antimicrobial respirators and can now bring them to market in all countries throughout the European Union. These respirators will be marketed as Noveko RD2 antimicrobial respirators.

29 Jul 2010

Harvard psychologists develop new tests to predict suicide risk

Two powerful new tests developed by psychologists at Harvard University show great promise in predicting patients' risk of attempting suicide.

29 Jul 2010

PFSCM wins Supply Chain Innovation Award, Best Value Supply Chain Provider Award

The Partnership for Supply Chain Management, a partner of the U.S. Agency for International Development under the U.S. President's Emergency Plan for AIDS Relief, has won two prestigious awards for groundbreaking work on PEPFAR's Supply Chain Management System. PFSCM received the Supply Chain Innovation Award and Best Value Supply Chain Provider Award during the European Supply Chain and Logistics Summit held in Prague.

29 Jul 2010

IBM, UPMC partner to provide redesigned SmartRoom solution with service-oriented architecture

IBM and UPMC (University of Pittsburgh Medical Center) are teaming up to bring "smarter" hospital rooms to patients nationwide. Created by UPMC three years ago to bring the right patient information to the bedside when it's needed, the high-tech "smart room" now features new capabilities, namely a system for automatically organizing and prioritizing the work of nurses and other caregivers. Under a new agreement, IBM will be the exclusive sales channel for the SmartRoom solution and will help to implement the technology for customers.

29 Jul 2010

Quest Diagnostics' Fragile X Syndrome test receives New York State health department approval

An accurate, faster testing option to identify female carriers and other patients with genetic abnormalities that cause Fragile X Syndrome is now available to physicians in all fifty states with the recent approval in New York. Fragile X is the leading cause of inherited mental retardation and the most common known single gene cause of autism.

From Quest Diagnostics 29 Jul 2010

New implantable sensor to continuously monitor tissue glucose

Bioengineers at the University of California, San Diego and GlySens Incorporated have developed an implantable glucose sensor and wireless telemetry system that continuously monitors tissue glucose and transmits the information to an external receiver. The paper, published in the July 28, 2010 issue of the journal Science Translational Medicine, describes the use of this glucose-sensing device as an implant in animals for over one year. After human clinical trials and FDA approval, the device may be useful to people with diabetes as an alternative to finger sticking and short-term, needle-like glucose sensors that have to be replaced every three to seven days.

29 Jul 2010

NDS Surgical Imaging introduces ConnectOR G2 visualization and informatics platform

NDS Surgical Imaging (NDSsi) today launched its next-generation visualization and informatics platform—the ConnectOR G2—with production units now shipping to customers. Based on the NDSsi technology vision of Medical Visualization Informatics (MVI), ConnectOR G2 medical-grade products are leading the industry in procedural efficacy by offering the unique ability to connect the realms of PACS imaging, surgical video and medical informatics.

29 Jul 2010

New test to predict suitable treatment for chronic myeloid leukemia patients

Scientists in Japan may have developed a way to accurately predict those patients who will resist treatment with imatinib, which is the standard of care for chronic myeloid leukemia (CML).

29 Jul 2010

Encision’s AEM system recognized as technology to eliminate visceral burns

Encision Inc, a medical device company owning patented surgical technology that is emerging as a standard of care in minimally-invasive surgery, recognized as a technology to eliminate visceral burns during monopolar electrical surgery.

29 Jul 2010

Generex reports positive trends in ongoing Oral-lyn buccal insulin spray global Phase III trial

Generex Biotechnology Corporation, the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced that it has now achieved 75% of the required number of per-protocol completers in its ongoing six month pivotal global Phase III study of Generex Oral-lyn™, the Company's proprietary buccal insulin spray product.

29 Jul 2010

Boston Scientific announces launch of Neuroform EZ Stent System in U.S. and Europe

Boston Scientific Corporation today announced the U.S. and European launches of the Neuroform EZ(TM) Stent System, its fourth-generation intracranial aneurysm stent system designed for use in conjunction with endovascular coiling to treat wide-necked aneurysms. The Company plans to launch the product immediately in both markets.

29 Jul 2010

CompuMed signs agreement with Lincoln High School Learning Centers

CompuMed, Inc., a telemedicine and medical informatics company, has entered into an agreement with the San Diego Unified School District's Lincoln High School Learning Centers to provide CompuMed's CardioGramKids electrocardiogram telemedicine technologies and services to the four schools that comprise the Lincoln High Learning Centers: the Lincoln High Schools of Public Safety, Science & Engineering, Arts and Social Justice.

28 Jul 2010

Device / Technology News

Devax's AXXESS Biolimus A9 Eluting Coronary Bifurcation Stent System receives CE Mark approval

Online pharmacy services Pharmahelper.com, QC Supply, and Kerr Drug earn NABP e-Advertiser Approval

NeoTract selects SYSPRO ERP

Ortho Kinematics: 23 patients enrolled in KineGraph VMA clinical study

Exact Sciences to demonstrate methylation specific technology at AACC annual meeting

Rotigotine provides clinically relevant improvements in RLS symptoms: Study

Positive results from phase I clinical trial of MultiStem in patients with AMI announced

Reliance on assistive devices can affect everyday life in multiple ways: Study

Noveko RD2 antimicrobial respirators obtain FFP2 classification

Harvard psychologists develop new tests to predict suicide risk

PFSCM wins Supply Chain Innovation Award, Best Value Supply Chain Provider Award

IBM, UPMC partner to provide redesigned SmartRoom solution with service-oriented architecture

Quest Diagnostics' Fragile X Syndrome test receives New York State health department approval

New implantable sensor to continuously monitor tissue glucose

NDS Surgical Imaging introduces ConnectOR G2 visualization and informatics platform

New test to predict suitable treatment for chronic myeloid leukemia patients

Encision’s AEM system recognized as technology to eliminate visceral burns

Generex reports positive trends in ongoing Oral-lyn buccal insulin spray global Phase III trial

Boston Scientific announces launch of Neuroform EZ Stent System in U.S. and Europe

CompuMed signs agreement with Lincoln High School Learning Centers

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News